Pediatric primary cutaneous marginal zone B-cell lymphoma treated with intralesional rituximab.
Park
Min Young
MY
Jung
Hyun Joo
HJ
Park
Jun Eun
JE
Kim
You Chan
YC
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D015552:Injections, Intralesional; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D000069283:Rituximab; D012878:Skin Neoplasms / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab